DNA Structure, Replication, Telomerase, and Medical Applications: Study Notes

Science to Society: Anthrax and DNA Replication

1. Background on Anthrax

Anthrax is an infectious disease caused by the bacterium Bacillus anthracis. It is notable for its ability to form hardy spores that can survive in harsh environments for decades. Anthrax is significant in both medical and security contexts due to its potential use as a bioterrorism agent.

• Cutaneous anthrax: Causes black, necrotic skin lesions.

• Gastrointestinal anthrax: Leads to severe digestive illness.

• Inhalation anthrax: The deadliest form, can cause respiratory distress, septicemia, and death if untreated.

Anthrax is a concern at the intersection of science, medicine, and security. The 2001 U.S. anthrax letter attacks highlighted its potential as a bioterrorism weapon.

2. DNA Replication and Antibiotic Targeting

At the molecular level, anthrax bacteria survive and multiply by replicating their DNA. Antibiotics can target this process to inhibit bacterial growth.

• DNA gyrase (a type II topoisomerase): Relieves supercoiling during DNA replication.

• Topoisomerase IV: Separates newly replicated chromosomes.

• Inhibiting these enzymes halts DNA replication, preventing bacterial growth.

Ciprofloxacin is an antibiotic that targets DNA gyrase and topoisomerase IV in Bacillus anthracis, blocking DNA replication and bacterial proliferation.

3. Science Core

• Antibiotic Mechanism: Ciprofloxacin inhibits DNA gyrase and topoisomerase IV, preventing bacterial DNA replication.

• Antibiotic Specificity: Antibiotics like penicillin target bacterial-specific processes, minimizing harm to human cells.

• Bacterial vs. Human DNA Replication: Bacterial DNA replication enzymes differ from those in humans, allowing selective targeting by antibiotics.

4. Science-to-Society Links

• Public Health Decisions: During the 2001 anthrax attacks, antibiotics were distributed widely as a precaution.

• Ethical Considerations: Decisions about mass antibiotic distribution involve weighing risks (e.g., antibiotic resistance) and benefits (e.g., preventing disease spread).

Case Study: Telomerase, DNA Structure, and Human Health

Part A: DNA Structure Refresher

DNA is composed of a sugar-phosphate backbone, nitrogenous bases, and forms a double helix. The ends of linear chromosomes are called telomeres.

• Telomeres: Repetitive DNA sequences (e.g., TTAGGG) that protect chromosome ends from deterioration.

• During DNA replication, telomeres shorten, which can limit cell lifespan.

Part B: Telomerase Function

Telomerase is an enzyme that adds DNA sequence repeats to the ends of chromosomes, counteracting telomere shortening and enabling cells to divide more times.

• Role in Replication: Telomerase solves the "end-replication problem" by extending telomeres.

• Cell Types with Telomerase: Germ cells, stem cells, and cancer cells typically have active telomerase.

• Somatic Cells: Most body cells lack telomerase activity, leading to gradual telomere shortening and limited lifespan.

Part C: Medical Applications

Manipulating telomerase activity has potential applications in aging and cancer therapy.

• Anti-aging: Activating telomerase in somatic cells could delay aging and promote cell renewal.

• Cancer: Uncontrolled telomerase activation can lead to immortalized cells and tumor growth.

• Therapeutic Balance: Medical interventions must balance the benefits of telomerase activation (e.g., tissue regeneration) with the risks (e.g., cancer).

Part D: Ethical and Societal Reflections

• Access to Therapies: Ethical questions arise about who should have access to anti-aging or telomerase-based therapies.

• Societal Impact: Unequal access to such treatments could exacerbate health disparities.

• Medical vs. Enhancement Use: Debate exists over whether anti-aging treatments should be considered medical therapy or enhancement.

DNA Analysis: PCR, Restriction Enzymes, and Gel Electrophoresis

1. DNA Sequence Analysis

DNA sequence differences can be identified by comparing normal and abnormal sequences. For example, sickle cell disease is caused by a single nucleotide mutation in the beta-globin gene.

• Normal Sequence: 3'-TATATACCTGACGGCCTGGAGAGAGAGTCTACTT-5'

• Abnormal Sequence: 3'-TATATACCTGACGCCTGTGGAGAGAGTCTACTT-5'

2. Polymerase Chain Reaction (PCR)

PCR is a technique used to amplify specific DNA segments. Each cycle doubles the amount of DNA:

• After $n$ cycles, the number of DNA copies is $2^n$.

• Primers are short DNA sequences that bind to specific regions, allowing selective amplification.

3. Restriction Enzyme Digestion

Restriction enzymes recognize specific DNA sequences and cut the DNA at those sites. For example, Mst II recognizes the sequence CCTGAGG.

• Sickle Cell Mutation: Alters the restriction site, changing the pattern of DNA fragments produced.

• By comparing fragment sizes, one can distinguish between normal and mutant alleles.

4. Gel Electrophoresis

Gel electrophoresis separates DNA fragments by size. DNA is loaded into a gel, and an electric current pulls fragments toward the positive electrode. Smaller fragments move faster and farther.

• Interpretation: The pattern of bands reveals the sizes of DNA fragments, allowing identification of genetic variants.

Example Table: DNA Fragment Sizes in Gel Electrophoresis

Lane	Sample	Fragment Sizes (bp)
1	Mom	800, 400
2	Dad	600, 400, 150
3	Child 1	800, 400
4	Child 2	600, 400, 150

Additional info: Table entries inferred based on typical gel electrophoresis results for restriction fragment length polymorphism (RFLP) analysis.

5. Inheritance and Genetic Analysis

• Each person inherits two copies of each gene (one from each parent).

• Alleles can be the same (homozygous) or different (heterozygous).

• By analyzing DNA fragments, one can determine inheritance patterns and diagnose genetic conditions.

6. Communicating Results

• Results from PCR, restriction digest, and gel electrophoresis must be explained in clear, non-technical language for patients and families.

• Key points include what the test detects, what the results mean, and implications for health and inheritance.